204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
Resource Type
Abstract
Authors
Ghorani, Ehsan ; Quartagno, Matteo ; Blackhall, Fiona ; O'Brien, Mary ; Ottensmeier, Christian ; Pizzo, Elena ; Spicer, James ; Gilbert, Duncan ; Baker, Alex ; Badman, Philip ; Milner-Watts, Charlotte ; D. d'Arienzo, Paolo ; Dangoor, Adam ; Adhikaree, Jason ; Evans, Joanne ; Leite, Pollyanna ; Keni, Manjusha ; Steele, Nicola ; Gomes, Fabio ; Gomez-Randulfe, Igor ; Belitei, Petru ; Stewart, Grant ; Barrie, Colin ; Geldart, Tom ; Jain, Pooja ; Liu, Justin KH ; Zubairi, Ishtaiq ; Muthukumar, Dakshinamoorthy ; Gray, Lucy ; Treece, Sarah ; Aleksic, Aleksandar ; Tsaknis, Georgios ; Rathbone, Emma ; Shaw, Paul ; Tarver, Kathryn ; Parmar, Mahesh K.B. ; Seckl, Michael J.
Source
In Lung Cancer April 2024 190 Supplement 1
Subject
Language
ISSN
0169-5002